Howmet Surges on Strong Q1 Demand, But Valuation Leaves No Room for Error

What happened

Howmet Aerospace reported a stronger-than-expected Q1 2026, citing broad demand across commercial aerospace, defense, and industrial gas turbines, with continued growth in higher-margin spares revenue. This Q1 performance aligns with management’s optimistic FY2026 guidance but does not yet validate the critical near-term swing factors: CAM integration outcomes and tariff pass-through timing. The stock, already trading at 67x P/E and 43x EV/EBITDA, has limited valuation support, making it highly sensitive to any negative surprise from these catalysts. While the spares-led earnings engine remains intact, the narrative is crowded and the risk/reward is skewed against buyers at current levels. The fundamental thesis hinges on observable milestones in the next two quarters, not on extrapolated Q1 momentum.

Implication

The Q1 beat does not change the thesis that Howmet is a high-quality compounder, but at these multiples investors are paying for flawless execution. The key risks—CAM integration, tariff lag, and OEM production caps—remain unresolved. Establishing a position near the attractive entry of $220 offers a better risk/reward than chasing momentum at $251+. The next two quarters will determine if the premium multiple is justified or if the stock needs to re-rate lower.

Thesis delta

No material shift; Q1 results were in line with the pre-existing optimistic narrative and do not validate the critical integration and timing risks. The DeepValue report's WAIT rating remains appropriate as the stock has moved to the upper end of the base case valuation with no new evidence that execution risks are receding. The thesis hinges on upcoming Q2/Q3 disclosures.